53 Results for "

AMPA Receptor Modulator

" in MedChemExpress (MCE) Product Catalog:
Products (53)

53 Results for "AMPA Receptor Modulator" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-116330A
CAS No.: 238074-03-8
Purity:  99.52%
Synonyms: Hyperforin DCHA
Hyperforin dicyclohexylammonium salt (Hyperforin DCHA) is a transient receptor canonical 6 (TRPC6) channels activator. Hyperforin dicyclohexylammonium salt modulates Ca 2+ levels by activating Ca 2+-conducting non-selective canonical TRPC6 channels. Hyperforin dicyclohexylammonium salt also shows diverse pharmacological activities including anti-depression, anti-tumor, anti-dementia, anti-diabetes. Hyperforin dicyclohexylammonium salt modulates γδ T cells to secret IL-17α, improves Imiquimod (HY-B0180)-induced psoriasis-like mice model .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10933
CAS No.: 154235-83-3
Purity:  99.94%
Synonyms: BDP 12
Target:  

iGluR

Research Areas:  

Neurological Disease

CX516 (BDP 12) is an ampakine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101165
CAS No.: 2259-96-3
Purity:  98.29%
Target:  

iGluR GABA Receptor

Research Areas:  

Neurological Disease

Cyclothiazide is a positive allosteric modulator of ionotropic AMPA-type glutamate receptors. Cyclothiazide inhibits GABAA receptors. Cyclothiazide is frequently used to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current. Cyclothiazide can potentiate responses to kainate in hippocampal neurons. Cyclothiazide has effects on glutamatergic neurotransmission. Cyclothiazide also induces epileptiform EEG activity accompanying behavioral seizures .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109046
CAS No.: 1038984-31-4
Purity:  99.39%
Synonyms: CX-1632; S-47445
Target:  

iGluR mTOR

Research Areas:  

Neurological Disease

Tulrampator (S-47445) is an orally active selective AMPA receptor modulator. Tulrampator possesses procognitive, enhancing synaptic plasticity, anti-depressant-anxiolytic-like, procognitive and potential neuroprotective properties. Tulrampator can be used for research of alzheimer’s disease and in major depressive disorder .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-90003
CAS No.: 72797-41-2
Tianeptine is an atypical antidepressant. Tianeptine is a moderate-intensity agonist of the μ-opioid receptor (MOR), and to a lesser extent, is an agonist of the δ-opioid receptor (DOR). Tianeptine is a glutamate modulator that can enhance AMPA receptor and antagonize NMDA receptor. tianeptine increases sensitivity of the α1 adrenergic receptor, which only manifests in chronic treatment. Tianeptine exerts neuroprotective effects under stress/inflammation-induced conditions, exhibiting anti-inflammatory and antioxidant properties. Tianeptine inhibits MMP-9 by suppressing the PI3K/Akt-mediated NF-κB pathway. Tianeptine can be used to alleviate symptoms of depression and anxiety, but does not cause sedative effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110175
CAS No.: 191744-13-5
Purity:  99.94%
Target:  

iGluR

Research Areas:  

Neurological Disease

CX614 is a positive variant modulator of AMPA receptors that enhances excitatory postsynaptic potentials (amplitude and duration) by blocking and slowing the inactivation of responses to glutamate and automatically evokes excitatory postsynaptic currents in neuronal cultures. CX614 can be used in the study of psychiatric disorders such as depression .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-90003A
CAS No.: 30123-17-2
Tianeptine sodium salt is an atypical antidepressant. Tianeptine sodium salt is a moderate-intensity agonist of the μ-opioid receptor (MOR), and to a lesser extent, is an agonist of the δ-opioid receptor (DOR). Tianeptine sodium salt is a glutamate modulator that can enhance AMPA receptor and antagonize NMDA receptor. Tianeptine sodium salt increases sensitivity of the α1 adrenergic receptor, which only manifests in chronic treatment. Tianeptine sodium salt exerts neuroprotective effects under stress/inflammation-induced conditions, exhibiting anti-inflammatory and antioxidant properties. Tianeptine sodium salt inhibits MMP-9 by suppressing the PI3K/Akt-mediated NF-κB pathway. Tianeptine sodium salt can be used to alleviate symptoms of depression and anxiety, but does not cause sedative effects .
loading...
    loading...
Cat. No.: HY-115864
CAS No.: 1358751-06-0
Purity:  99.89%
Synonyms: TAK-653; NBI-1065845
Target:  

iGluR Lipoxygenase

Research Areas:  

Neurological Disease

Osavampator (TAK-653) is a AMPA receptor positive allosteric modulator. Osavampator selectively binds to AMPA-R in a glutamate-dependent manner and induces Ca2+ influx in hGluA1i CHO cells (EC50 = 3.3 μM). Osavampator improves learning and memory in many models. Osavampator is can be used for the research of depressive disorders .
loading...
    loading...
Cat. No.: HY-118424
CAS No.: 2036081-86-2
Target:  

iGluR

JNJ-55511118 is a selective TARP γ-8 binding AMPA receptor modulator with oral bioavailability and blood-brain barrier permeability, with a Ki of 26 nM. JNJ-55511118 reduces voluntary intake of sweetened alcohol in male mice. In rodent models, JNJ-55511118 inhibits hippocampal neurotransmission, reduces specific electroencephalogram frequency bands, induces transient hyperlocomotion, impairs learning and memory abilities, and exerts anticonvulsant effects. JNJ-55511118 is applicable to research related to alcohol use disorder and seizures .
loading...
    loading...
Cat. No.: HY-101528
CAS No.: 22503-72-6
Purity:  99.33%
Target:  

iGluR

Research Areas:  

Neurological Disease

IDRA 21 is a positive and orally active modulator of the AMPA receptor. IDRA 21 facilitates excitatory neurotransmission via GluR1/2 receptors. IDRA 21 has the potential for the research of cognitive/memory disorders, including those associated with aging .
loading...
    loading...
Cat. No.: HY-175443
CAS No.: 2034182-75-5
Target:  

iGluR

Research Areas:  

Neurological Disease

AMPA-IN-3 is an AMPA receptor inhibitor. AMPA-IN-3 inhibits TARP J2-dependent AMPA receptor activity with a pIC50 value of 10.7. A AMPA-IN-3 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-177873
CAS No.: 620940-01-4
Target:  

iGluR

Research Areas:  

Neurological Disease

AMPA receptor modulator-10 (Compound 9a) is an orally active AMPA receptor (AMPAR) positive allosteric modulator. AMPA receptor modulator-10 exhibits potent activity (pEC50 = 5.0) on the GluA2 subtype of AMPAR, significantly enhancing glutamate-induced calcium influx and current responses. AMPA receptor modulator-10 can reverse the memory impairment induced by Scopolamine (HY-N0296) and enhance cognitive function. AMPA receptor modulator-10 can be used for the research of neurological disease, such as schizophrenia .
loading...
    loading...
Cat. No.: HY-139897
CAS No.: 867276-98-0
Purity:  99.86%
Target:  

iGluR

Research Areas:  

Neurological Disease

CX 717 is a positive allosteric modulator of AMPA receptor. Antidepressant-like effect. CX 717 can be used for the research of adult attention deficit hyperactivity disorder (ADHD) .
loading...
    loading...
Cat. No.: HY-112781
CAS No.: 1258963-59-5
Purity:  99.85%
Synonyms: PF-04958242
Target:  

iGluR

Research Areas:  

Neurological Disease

Pesampator (PF-04958242) is a potent and highly selective positive allosteric modulator of AMPA receptor (an AMPA potentiator) with an EC50 of 310 nM and a Ki of 170 nM .
loading...
    loading...
Cat. No.: HY-107520
CAS No.: 295325-62-1
Purity:  99.6%
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

MNI-caged-L-glutamate is an inert photolabile glutamate precursor. MNI-caged-L-glutamate does not modulate NMDA and AMPA receptor function in cultured neurones. MNI-caged-L-glutamate can be used for research on neurotransmitters .
loading...
    loading...
Cat. No.: HY-10936
CAS No.: 175340-20-2
Purity:  99.85%
Target:  

iGluR

Research Areas:  

Neurological Disease

S 18986 is a selective, orally active, brain penetrant positive allosteric modulator of AMPA-type receptors. S 18986 shows cognitive enhancing properties in rodents. S 18986 activates the release of noradrenaline and acetylcholine in rat hippocampus and enhances rat memory in object-recognition tests .
loading...
    loading...
Cat. No.: HY-136275
CAS No.: 2034181-36-5
Purity:  98.55%
Target:  

iGluR

Research Areas:  

Others

AMPA receptor modulator-2 (Example 134) is a AMPA receptor modulator, with a pIC50 of 10.1 for TARPγ8 dependent AMPA receptor . pIC50 = -lgIC50.
loading...
    loading...
Cat. No.: HY-10937
CAS No.: 211735-76-1
Purity:  99.87%
Synonyms: CX-691; Org24448
Target:  

iGluR

Research Areas:  

Neurological Disease

Farampator (CX-691;Org24448) is an AMPA receptor positive modulator.
loading...
    loading...
Cat. No.: HY-12508
CAS No.: 380607-77-2
Purity:  99.31%
Target:  

iGluR

Research Areas:  

Neurological Disease

CMPDA is a positive allosteric modulator of AMPA receptors with EC50s of 45.4 ± 4.2 nM/63.4 ± 5.6 nM for GluA2i/GluA2o receptor.
loading...
    loading...
Cat. No.: HY-13456
CAS No.: 211311-95-4
Purity:  98.27%
Target:  

iGluR

Research Areas:  

Neurological Disease

LY-404187 is a potent, selective and centrally active positive allosteric modulator of AMPA receptors, with the EC50s of 5.65, 0.15, 1.44, 1.66 and 0.21 µM for GluR1i, GluR2i, GluR2o, GluR3i and GluR4i, respectively. LY-404187 has therapeutic potential in a number of psychiatric disorders and neurodegenerative diseases .
loading...
    loading...